IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
15.65
-0.04 (-0.25%)
Nov 5, 2024, 12:44 PM EST - Market open

IGM Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
9284857289522,8181,165
Upgrade
Market Cap Growth
-10.70%-33.39%-23.49%-66.22%141.87%-
Upgrade
Enterprise Value
7141392877222,651934
Upgrade
Last Close Price
15.698.3117.0129.3388.2938.16
Upgrade
PE Ratio
--1.76-3.20-5.95-33.37-7.96
Upgrade
PS Ratio
139.30227.82681.46---
Upgrade
PB Ratio
7.602.392.543.897.384.85
Upgrade
P/FCF Ratio
-2.30-2.37-45.36-6.89-33.01-24.56
Upgrade
P/OCF Ratio
-2.41-2.52-124.46-7.62-41.52-25.83
Upgrade
EV/Sales Ratio
245.1765.47268.87---
Upgrade
EV/EBITDA Ratio
-0.67-0.55-1.30-4.49-32.23-21.26
Upgrade
EV/EBIT Ratio
-0.65-0.53-1.26-4.37-31.83-20.98
Upgrade
EV/FCF Ratio
-0.87-0.68-17.90-5.22-31.05-19.67
Upgrade
Debt / Equity Ratio
0.320.200.140.120.030.06
Upgrade
Debt / FCF Ratio
-0.22-0.20-2.56-0.21-0.14-0.31
Upgrade
Asset Turnover
0.010.000.00---
Upgrade
Quick Ratio
6.837.979.578.2621.2525.31
Upgrade
Current Ratio
7.068.189.818.6721.6526.04
Upgrade
Return on Equity (ROE)
-115.71%-100.48%-83.09%-52.71%-26.16%-36.66%
Upgrade
Return on Assets (ROA)
-35.99%-34.91%-35.11%-29.24%-15.54%-20.96%
Upgrade
Return on Capital (ROIC)
-63.69%-57.16%-47.33%-30.95%-16.04%-21.81%
Upgrade
Earnings Yield
-23.68%-50.78%-30.35%-17.35%-2.89%-3.70%
Upgrade
FCF Yield
-18.93%-42.17%-2.20%-14.52%-3.03%-4.07%
Upgrade
Buyback Yield / Dilution
-34.98%-25.92%-24.09%-8.88%-241.82%-1953.40%
Upgrade
Total Shareholder Return
-34.98%-25.92%-24.09%-8.88%-241.82%-1953.40%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.